Navigation Links
Wyeth Pharmaceuticals Announces Organizational Change
Date:6/26/2008

- Andreas Krebs Named President of Europe/Middle East/Africa and Canada -

COLLEGEVILLE, Pa., June 26 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today the appointment of Andreas Krebs, 50, to President - Europe/Middle East/Africa and Canada, effective immediately. In this new role, Mr. Krebs will report to Joseph M. Mahady, President - Wyeth Pharmaceuticals, and Senior Vice President, Wyeth.

Mr. Krebs joined the Company in July 2003 as General Manager, Wyeth Germany, and since that time has worked to transform the German affiliate into one of the fastest growing companies in the market. He serves on the Board of the VFA (Germany's trade organization for research companies) and is a member of the Board of Trustees in the Max Planck Institute for Molecular Biomedicine and the Paul Ehrlich Society for Chemotherapy.

Prior to joining Wyeth, Mr. Krebs was with Bayer for approximately 20 years, where he held a variety of pharmaceutical marketing and sales leadership positions in Europe, Latin America, Asia and Canada. He holds a degree in Commercial Management and Business Administration from the In-House Academy of Woelm Pharma, Eschwege, Germany.

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products, nutritionals and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.


'/>"/>
SOURCE Wyeth Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.
2. Wyeth to Present at the 2008 Citi Investment Research Global Healthcare Conference
3. Wyeth Research Head Robert R. Ruffolo, Jr., Ph.D., Announces Retirement
4. Wyeth Chairman Robert Essner Announces June 27 Retirement
5. Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
6. Wyeth to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
7. Wyeth Sets Webcast And Conference Call For 2008 First Quarter Earnings
8. Wyeth To Appeal Arkansas Hormone Therapy Trial Verdicts
9. Wyeth Pharmaceuticals Ends Collaboration Agreements with Solvay Pharmaceuticals for Bifeprunox and Other Compounds
10. Wyeth Announces Executive Change in Finance Organization
11. Wyeth Announces Election of Timothy P. Cost as Senior Vice President, Corporate Affairs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/11/2017)... 11, 2017  Market researcher Kalorama Information ... article regarding the telemedicine market.  The telemedicine ... Information.  The article, "Heart and Asthma ...  used information from Kalorama Information,s Remote Patient ... Market  (Sleep, Diabetes, Vital Signs /EKG ...
(Date:8/11/2017)... ... August 11, 2017 , ... “There is an increasing ... alternatives to synthetic ingredients,” said Matt Hundt, President of Third Wave Bioactives. “Combining ... presence and know-how of Biorigin will allow us to bring truly novel fermented ...
(Date:8/10/2017)... ... 09, 2017 , ... The era of using extracellular vesicles ... team at Capricor Therapeutics, Inc. utilized a cardiosphere-derived stem-like cell culturing process to ... Travis Antes, head of analytical development at Capricor Therapeutics Inc., will be the ...
(Date:8/10/2017)... ... August 09, 2017 , ... ... biomedical optics laboratories — the Wellman Center for Photomedicine, the Manstein Lab in ... and the Beckman Laser Institute at University of California, Irvine — and the ...
Breaking Biology Technology:
(Date:4/11/2017)... , Apr. 11, 2017 Research and Markets ... 2017-2021" report to their offering. ... The global eye tracking market to grow at a CAGR ... Global Eye Tracking Market 2017-2021, has been prepared based on an ... the market landscape and its growth prospects over the coming years. ...
(Date:4/5/2017)... April 5, 2017  The Allen Institute for Cell ... Explorer: a one-of-a-kind portal and dynamic digital window into ... data, the first application of deep learning to create ... cell lines and a growing suite of powerful tools. ... these and future publicly available resources created and shared ...
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
Breaking Biology News(10 mins):